Telerehabilitation in Coronary Heart Disease (TRiCH)
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Myocardial Infarction, Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic Guidance
About this trial
This is an interventional treatment trial for Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Eligibility Criteria
Inclusion Criteria:
- Patients with CAD (post-PCI, post-MI, post-CABG)
- Patients on optimal medical treatment and stable with regard to symptoms and pharmacotherapy for at least 6 weeks
- Patients have successfully completed the 3 month ambulatory cardiac rehabilitation in hospital program
- 39 yrs < age < 76 years
- access to internet facilities or PC at home
Exclusion Criteria:
- Significant undercurrent illness last 6 weeks
- Known severe ventricular arrhythmia with functional or prognostic significance; significant myocardial ischemia, hemodynamic deterioration or exercise-induced arrhythmia at screening or heart disease that limits exercise
- Co-morbidity that may significantly influence one-year prognosis
- Functional of mental disability that may limit exercise
Sites / Locations
- KU Leuven
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
No Intervention
Center-based cardiac rehabilitation
Home-based training with telemonitoring guidance
Control
Patients randomized to the center-based training group will continue their training sessions at the outpatient clinics of UZ Leuven under direct supervision of physical therapists
Patients will receive an patient-tailored exercise prescription and will be asked to perform the exercise sessions in their home environment wearing heart rate monitors. Training data will be accessed by the research group on weekly basis in order to keep a record of frequency; duration and intensity of the sessions. Feedback will be given weekly to every patient.